Date: 2012-07-10
Type of information: Capital increase
Company: Integragen (France)
Investors: funds managed by A Plus Finance.
Amount: €2 million
Funding type: capital increase
Planned used: these funds will support the development of genetic testing in liver cancer and colon cancer as well as continued efforts of marketing and R & D in the molecular diagnosis of autism.
Others: IntegraGen, a biotechnology company specialized in the development and commercialization of molecular diagnostic tests in autism and oncology, has completed a capital increase of € 2 million from funds managed by A Plus Finance.
Therapeutic area: Cancer - Oncology - CNS diseases - Psychiatric diseases
